Ipca Lab

Short Call | Will China's aggressive stimulus eclipse India's investment allure? Sapphire Foods, Ipca Labs in focus

Invest for the long haul. Don’t get too greedy and don’t get too scared. - Shelby M.C. Davis

Ipca to acquire 33.38% stake in Unichem Laboratories for Rs 1,034 crore

Additionally, the Company's Board of Directors has also given the go-ahead to make an open offer to Unichem Laboratories' public shareholders in order to purchase from them up to 26% of the fully diluted outstanding equity share capital of the said company.

Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct

Net Sales are expected to decrease by 7.8 percent Y-o-Y (up 11.9 percent Q-o-Q) to Rs 1,443 crore, according to ICICI Direct.

Ipca Lab Q1 PAT may dip 53.5% YoY to Rs 207.6 cr: ICICI Direct

Net Sales are expected to decrease by 13.9 percent Y-o-Y (up 18.6 percent Q-o-Q) to Rs 1321.4 crore, according to ICICI Direct.

Prabhudas Lilladher bets on 8 midcaps for long term

Prabhudas Lilladher has come out with its report on top picks in mid cap.

Drug makers in India to sustain 'premium' valuations: HSBC

HSBC raises target prices for some Indian drug makers saying "robust" earnings will help sustain the "premium" valuations in the sector.

Bull's Eye: Buy Bata, United Spirits, Godrej Cons

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Pharmaceutical results preview for Q3FY12: Emkay

Emkay Global Financial Services has come with its December quarterly earning estimates for pharmaceutical sector. According to the research firm the sector is expected to report a growth of 18% YoY (5% QoQ) in revenues partly driven by Rupee depreciation which is likely to be 4-5% of the overall growth.